½ÃÀ庸°í¼­
»óǰÄÚµå
1618790

¼¼°èÀÇ ¾È°ú¿ë µð¹ÙÀ̽º ½ÃÀå : µð¹ÙÀ̽ºº°, ¿ëµµº° ¿¹Ãø(2025-2030³â)

Ophthalmology Devices Market by Devices (Diagnostic & Monitoring Devices, Surgical Devices, Vision Care), Application (Academy & Research Laboratory, Ambulatory Surgical Centers, Hospitals & Ophthalmology Clinics) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 183 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

¾È°ú¿ë µð¹ÙÀ̽º ½ÃÀåÀº 2023³â¿¡ 679¾ï 4,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 709¾ï 3,000¸¸ ´Þ·¯¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 4.52%·Î ¼ºÀåÇϰí, 2030³â¿¡´Â 926¾ï 1,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¾È°ú¿ë µð¹ÙÀ̽º ½ÃÀå¿¡´Â ´« »óÅÂ¿Í Áúº´ÀÇ Áø´Ü, Ä¡·á, °ü¸®¿¡ »ç¿ëµÇ´Â ±¤¹üÀ§ÇÑ ±â±¸¿Í µµ±¸°¡ Æ÷ÇԵǾî ÀÖ½À´Ï´Ù. °í·ÉÈ­ »çȸ ¹× ½ºÅ©¸° ÀÌ¿ë ½Ã°£ Áõ°¡´Â ÀÌ·¯ÇÑ Àåºñ¸¦ ÇÊ¿ä·Î ÇÕ´Ï´Ù. ½ÃÀå ¼ºÀåÀÇ ¿µÇâ ±× ¿øÀÎÀº ¸Á¸· ¹®Á¦·Î À̾îÁö´Â ´ç´¢º´ÀÇ ÀÌȯÀ² »ó½Â, Á¤È®ÇÑ Áø´ÜÀ» À§ÇÑ AI¿Í ¸Ó½Å·¯´× µîÀÇ ±â¼ú Áøº¸, ½Ã·Â Äɾ ÃÊÁ¡À» ¸ÂÃá Á¤ºÎÀÇ ´ëó µîÀ» µé ¼ö ÀÖ½À´Ï´Ù. ±âȸ´Â ¹ÌÃæÁ· ÀÇ·á ¼ö¿ä¿Í ÇコÄɾî ÁöÃâ Áõ°¡¸¦ ¼ö¹ÝÇÏ´Â ½ÅÈï ½ÃÀå¿¡ ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °¡´É¼ºÀÌ ÀÖÀ½¿¡µµ ºÒ±¸Çϰí, °úÁ¦·Î´Â ÷´Ü ÀåºñÀÇ °í°¡°¡ º¸±ÞÀ» Á¦ÇÑÇϰí ÀÖÀ½, ±ÔÁ¦ ´ç±¹ÀÇ ½ÂÀÎ ÇÁ·Î¼¼½º°¡ ¾ö°ÝÇÏ´Ù´Â Á¡, °í±Þ Àåºñ¸¦ Á¶ÀÛ ¼÷·ÃµÈ Àü¹®°¡°¡ ºÎÁ·ÇÕ´Ï´Ù. ¶ÇÇÑ COVID-19ÀÇ ´ë À¯ÇàÀÌ ¼±ÅÃÀû ¼ö¼ú Áö¿¬À» À¯¹ßÇÏ¿© ¼öÀÍ Ã¢Ãâ¿¡ ¿µÇâÀ» ¹ÌÃÆ½À´Ï´Ù. ±â¼ú Çõ½Å°ú ¿¬±¸ÀÇ ¿©Áö°¡ Å®´Ï´Ù. ±â¾÷Àº ÁÖ¿ä ¼ºÀå Àü·«À¸·Î ³·Àº ħ½À ¼ö¼ú µµ±¸ÀÇ °³¹ß°ú ¿ø°Ý Áø´ÜÀ» À§ÇÑ ¿ø°Ý ÀÇ·á Ȱ¿ë¿¡ ÁÖ·Â ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±Þ¼ÓÇÑ ±â¼ú µµÀÔ°ú ȯÀÚ Á᫐ ÄɾîÀÇ ÃßÁøÀÌ ½ÃÀåÀÇ ¿ªµ¿ÀûÀÎ º¯È­¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù.±â¼ú Çõ½ÅÀ̳ª ±ÔÁ¦ »óȲÀÇ º¯È­¿¡ ½Å¼ÓÇÏ°Ô ´ëÀÀÇØ, ¹Ì°³Ã´ ½ÃÀå¿¡ ÁøÀÔÇÒ ¼ö ÀÖ´Â ±â¾÷Àº ÁøÈ­ÇÏ´Â ½ÃÀå »óȲ Áß¿¡¼­ Å« ¼ºÀåÀ» ÀÌ·ê ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 679¾ï 4,000¸¸ ´Þ·¯
ÃßÁ¤³â(2024) 709¾ï 3,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 926¾ï 1,000¸¸ ´Þ·¯
CAGR(%) 4.52%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ¾È°ú¿ë µð¹ÙÀ̽º ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

¾È°ú¿ë µð¹ÙÀ̽º ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ȹµæÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ»º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¼¼°èÀÇ ¾Èº´ À¯º´·ü Áõ°¡
    • ´« °Ç°­¿¡ ´ëÇÑ ÀǽÄÀÇ ³ô¾ÆÁü°ú ¾È°ú ÀÇ·á¿¡ÀÇ ¾×¼¼½ºÀÇ °³¼±
    • Àúħ½À ¼ö¼ú¿¡ÀÇ ±âÈ£ÀÇ È®´ë
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¾È°ú¿ë µð¹ÙÀ̽ºÀÇ ºÒ¸®ÇÑ ¸®ÄÝ
  • ½ÃÀå ±âȸ
    • ¾È°ú ÀÇ·áµð¹ÙÀ̽ºÀÇ ±â¼úÀû Áøº¸
    • °í¼öÁØÀÇ ÀÎÁ¤ ¾È°ú Ŭ¸®´ÐÀÇ ¼³¸³
  • ½ÃÀåÀÇ °úÁ¦
    • µð¹ÙÀ̽ºÀÇ ±â¼úÀû ÇѰè¿Í ¿î¿ë»óÀÇ ¹®Á¦

Porter's Five Force : ¾È°ú¿ë µð¹ÙÀ̽º ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Force Framework´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÒ ¼ö ÀÖµµ·Ï µµ¿ÍÁÝ´Ï´Ù. ´ç½ÅÀº ´õ °­ÀÎÇÑ ½ÃÀå¿¡¼­ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ¾È°ú¿ë µð¹ÙÀ̽º ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ¾È°ú¿ë ÀåÄ¡ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÏ¸é ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ°¡µÇ¾î ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ¾È°ú¿ë µð¹ÙÀ̽º ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

¾È°ú¿ë µð¹ÙÀ̽º ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®Àº ½ÃÀåÀÇ ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í, º¥´õ´Â °æÀïÀÌ °ÝÈ­ÇÏ´Â °¡¿îµ¥ ÀÚ½ÅÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«ÀûÀÎ ÀÇ»ç °áÁ¤À» ³»¸®´Âµ¥ ÇÊ¿äÇÕ´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ¾È°ú¿ë µð¹ÙÀ̽º ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ¾È°ú¿ë µð¹ÙÀ̽º ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. 4°³ÀÇ »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× ±ÇÀå : ¾È°ú¿ë µð¹ÙÀ̽º ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

¾È°ú¿ë µð¹ÙÀ̽º ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾ò°í ÀÇ»ç°áÁ¤À» ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¼¼°è¿¡¼­ ¾ÈÁúȯÀÇ ÀÌȯÀ²ÀÌ Áõ°¡
      • ´« °Ç°­¿¡ ´ëÇÑ ÀǽÄÀÇ ³ô¾ÆÁü°ú ¾È°ú ÀÇ·á¿¡ÀÇ ¾×¼¼½ºÀÇ °³¼±
      • Àúħ½À ¼ö¼ú ¼±È£ È®´ë
    • ¾ïÁ¦¿äÀÎ
      • ¾È°ú¿ë µð¹ÙÀ̽ºÀÇ ºÒ¸®ÇÑ ¸®ÄÝ
    • ±âȸ
      • ¾È°ú µð¹ÙÀ̽ºÀÇ ±â¼úÀû Áøº¸
      • °í¼öÁØÀÇ ÀÎÁ¤À» ¹ÞÀº ¾È°ú Ŭ¸®´ÐÀÇ ¼³¸³
    • °úÁ¦
      • µð¹ÙÀ̽ºÀÇ ±â¼úÀû Á¦ÇѰú Á¶ÀÛ»óÀÇ ¹®Á¦
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
    • ÀåÄ¡ : ¾È°ú¿¡¼­ÀÇ Áø´Ü ¹× ¸ð´ÏÅ͸µ ÀåÄ¡ÀÇ µµÀÔÀÌ ±ÞÁõÇϰí ÀÖ¾î ¾ÈÁúȯ °ü¸®¿¡ ÇʼöÀûÀÔ´Ï´Ù.
    • ÀÀ¿ë: º´¿øÀ̳ª ¾È°ú Ŭ¸®´Ð¿¡¼­ ¾È°ú¿ë µð¹ÙÀ̽ºÀÇ È°¿ë ÁøÈ­
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ¾È°ú¿ë µð¹ÙÀ̽º ½ÃÀå µð¹ÙÀ̽ºº°

  • Áø´Ü ¹× °¨½Ã ÀåÄ¡
    • ÀÚµ¿±¼Àýµµ °Ë»ç±â¿Í °¢¸·°è
    • °¢¸· ÅäÆ÷±×·¡ÇÇ ½Ã½ºÅÛ
    • ¾È°ú¿ë ÃÊÀ½ÆÄ ¿µ»ó Áø´Ü ½Ã½ºÅÛ
    • ±¤ °£¼· ´ÜÃþ ÃÔ¿µ ÀåÄ¡
    • ½Ã¾ß°è/½Ã¾ß ºÐ¼® ÀåÄ¡
    • Æ÷·ÓÅÍ
    • ·¹Æ¼³ë½ºÄÚÇÁ
    • ½ºÆäŧ·¯ Çö¹Ì°æ
    • ÆÄ¸é ¼öÂ÷°è
  • ¿Ü°ú¿ë µð¹ÙÀ̽º
    • ¹é³»Àå ¼ö¼ú ÀåÄ¡
    • ³ì³»Àå ¼ö¼ú ÀåÄ¡
    • ¾È°ú¿ë Çö¹Ì°æ
    • ±¼Àý ±³Á¤ ¼ö¼ú ÀåÄ¡
    • À¯¸®Ã¼ ¸Á¸· ¼ö¼ú ÀåÄ¡
  • ºñÀü Äɾî

Á¦7Àå ¾È°ú¿ë µð¹ÙÀ̽º ½ÃÀå : ¿ëµµº°

  • ¾ÆÄ«µ¥¹Ì ¹× ¿¬±¸½Ç
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • º´¿ø¡¤¾È°ú

Á¦8Àå ¾Æ¸Þ¸®Ä« ¾È°ú¿ë µð¹ÙÀ̽º ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ¾È°ú¿ë µð¹ÙÀ̽º ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä« ¾È°ú¿ë µð¹ÙÀ̽º ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
    • Zeiss, 10¾ï ´Þ·¯·Î ³×´ú¶õµå ¾È°ú ¿¬±¸¼¾Å͸¦ Àμö
    • Kubota Vision, AUROLAB»ç¿Í eyeMOÀÇ °³¹ß¡¤Á¦Á¶¡¤°ø±Þ¡¤ÆÇ¸Å ¶óÀ̼±½º °è¾àÀ» ü°á
    • Bausch + Lomb, StableVisc Á¡Âø¼º ¾È°ú Á¡¼º ¿Ü°ú¿ë µð¹ÙÀ̽º¿Í TotalVisc Á¡Åº¼º ½Ã½ºÅÛÀÇ ¹Ì±¹¿¡¼­ÀÇ ¹ß¸Å¸¦ ¹ßÇ¥
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Alcon Inc.
  • Bausch & Lomb Incorporated by Valeant Pharmaceuticals International
  • Canon Medical Systems Corporation
  • Carl Zeiss AG
  • ClearSight
  • Diamatrix Ltd.
  • EssilorLuxottica
  • Eyenovia, Inc.
  • F. Hoffmann-La Roche AG
  • GWS Surgicals LLP
  • Haag-Streit Group by Metal Zug
  • Halma PLC
  • HEINE Optotechnik
  • Honeywell International Inc.
  • Hoya Corporation
  • Johnson & Johnson Services, Inc.
  • Luneau Technology Operations SAS
  • Nidek Co. Ltd.
  • Ophtec BV
  • Ophtechnics Unlimited
  • Paramount Surgimed Ltd.
  • STAAR Surgical Company
  • Stryker Corporation
  • Topcon Corporation
  • Unique Technologies, Inc.
  • Ziemer Ophthalmic Systems AG
JHS 24.12.30

The Ophthalmology Devices Market was valued at USD 67.94 billion in 2023, expected to reach USD 70.93 billion in 2024, and is projected to grow at a CAGR of 4.52%, to USD 92.61 billion by 2030.

The ophthalmology devices market encompasses a broad range of instruments and tools used in the diagnosis, treatment, and management of eye conditions and diseases. These devices are necessary to address the growing prevalence of ophthalmic disorders globally, such as cataracts, glaucoma, and age-related macular degeneration, driven by aging populations and increased screen time. Applications of these devices are found in refractive surgery, diagnostics, and vision care, with their end-use primarily concentrated across hospitals, clinics, and ambulatory surgical centers. Influencing factors for market growth include the rising incidence of diabetes leading to retinal issues, technological advancements such as AI and machine learning for accurate diagnostics, and government initiatives focussing on vision care. Key growth opportunities lie in emerging markets with unmet medical needs and increasing healthcare expenditure. Players should consider expanding their geographic reach, developing user-friendly devices, and engaging in strategic partnerships to leverage these opportunities. Despite this potential, challenging factors include the high cost of advanced devices limiting widespread adoption, stringent regulatory approval processes, and the shortage of skilled professionals to operate sophisticated equipment. Additionally, the COVID-19 pandemic induced a delay in elective procedures, impacting revenue generation. There is substantial scope for innovation and research in early diagnosis tools, wearable eye trackers, and portable devices for at-home patient monitoring. Businesses can focus on developing minimally invasive surgical tools and leveraging telemedicine for remote diagnostics as key growth strategies. The ophthalmology devices market is competitive, with rapid technological adoption and a push towards patient-centric care leading to dynamic market shifts. Firms that can swiftly innovate, respond to technological and regulatory changes, and penetrate untapped markets will likely garner significant growth in this evolving landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 67.94 billion
Estimated Year [2024] USD 70.93 billion
Forecast Year [2030] USD 92.61 billion
CAGR (%) 4.52%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Ophthalmology Devices Market

The Ophthalmology Devices Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of eye diseases worldwide
    • Rising awareness of eye health and improved access to eye care
    • Expanding preference for minimally invasive surgeries
  • Market Restraints
    • Adverse recalls of ophthalmology devices
  • Market Opportunities
    • Technological advancements in ophthalmological devices
    • Establishment of high-standard and certified eye clinics
  • Market Challenges
    • Technical limitations and operational issues of the devices

Porter's Five Forces: A Strategic Tool for Navigating the Ophthalmology Devices Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Ophthalmology Devices Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Ophthalmology Devices Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Ophthalmology Devices Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Ophthalmology Devices Market

A detailed market share analysis in the Ophthalmology Devices Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Ophthalmology Devices Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Ophthalmology Devices Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Ophthalmology Devices Market

A strategic analysis of the Ophthalmology Devices Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Ophthalmology Devices Market, highlighting leading vendors and their innovative profiles. These include Alcon Inc., Bausch & Lomb Incorporated by Valeant Pharmaceuticals International, Canon Medical Systems Corporation, Carl Zeiss AG, ClearSight, Diamatrix Ltd., EssilorLuxottica, Eyenovia, Inc., F. Hoffmann-La Roche AG, GWS Surgicals LLP, Haag-Streit Group by Metall Zug, Halma PLC, HEINE Optotechnik, Honeywell International Inc., Hoya Corporation, Johnson & Johnson Services, Inc., Luneau Technology Operations SAS, Nidek Co. Ltd., Ophtec B.V., Ophtechnics Unlimited, Paramount Surgimed Ltd., STAAR Surgical Company, Stryker Corporation, Topcon Corporation, Unique Technologies, Inc., and Ziemer Ophthalmic Systems AG.

Market Segmentation & Coverage

This research report categorizes the Ophthalmology Devices Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Devices, market is studied across Diagnostic & Monitoring Devices, Surgical Devices, and Vision Care. The Diagnostic & Monitoring Devices is further studied across Autorefractors & Keratometers, Corneal Topography Systems, Ophthalmic Ultrasound Imaging Systems, Optical Coherence Tomography Scanners, Perimeters/Visual Field Analysers, Phoropters, Retinoscope, Specular Microscope, and Wavefront Aberrometer. The Surgical Devices is further studied across Cataract Surgery Devices, Glaucoma Surgery Devices, Ophthalmic Microscopes, Refractive Surgery Devices, and Vitreoretinal Surgery Devices.
  • Based on Application, market is studied across Academy & Research Laboratory, Ambulatory Surgical Centers, and Hospitals & Ophthalmology Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of eye diseases worldwide
      • 5.1.1.2. Rising awareness of eye health and improved access to eye care
      • 5.1.1.3. Expanding preference for minimally invasive surgeries
    • 5.1.2. Restraints
      • 5.1.2.1. Adverse recalls of ophthalmology devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in ophthalmological devices
      • 5.1.3.2. Establishment of high-standard and certified eye clinics
    • 5.1.4. Challenges
      • 5.1.4.1. Technical limitations and operational issues of the devices
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Devices: Burgeoning adoption of diagnostic and monitoring devices in ophthalmology crucial for the management of eye diseases
    • 5.2.2. Application: Evolving usage of ophthalmology devices in hospitals and ophthalmology clinics
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Ophthalmology Devices Market, by Devices

  • 6.1. Introduction
  • 6.2. Diagnostic & Monitoring Devices
    • 6.2.1. Autorefractors & Keratometers
    • 6.2.2. Corneal Topography Systems
    • 6.2.3. Ophthalmic Ultrasound Imaging Systems
    • 6.2.4. Optical Coherence Tomography Scanners
    • 6.2.5. Perimeters/Visual Field Analysers
    • 6.2.6. Phoropters
    • 6.2.7. Retinoscope
    • 6.2.8. Specular Microscope
    • 6.2.9. Wavefront Aberrometer
  • 6.3. Surgical Devices
    • 6.3.1. Cataract Surgery Devices
    • 6.3.2. Glaucoma Surgery Devices
    • 6.3.3. Ophthalmic Microscopes
    • 6.3.4. Refractive Surgery Devices
    • 6.3.5. Vitreoretinal Surgery Devices
  • 6.4. Vision Care

7. Ophthalmology Devices Market, by Application

  • 7.1. Introduction
  • 7.2. Academy & Research Laboratory
  • 7.3. Ambulatory Surgical Centers
  • 7.4. Hospitals & Ophthalmology Clinics

8. Americas Ophthalmology Devices Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Ophthalmology Devices Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Ophthalmology Devices Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Zeiss Acquires Dutch Ophthalmic Research Center in USD 1 Billion Deal
    • 11.3.2. Kubota Vision Announces Agreement with AUROLAB for Development, Manufacturing, Supply, and Distribution License of eyeMO
    • 11.3.3. Bausch + Lomb Announces U.S. Launch of StableVisc Cohesive Ophthalmic Viscosurgical Device and TotalVisc Viscoelastic System
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alcon Inc.
  • 2. Bausch & Lomb Incorporated by Valeant Pharmaceuticals International
  • 3. Canon Medical Systems Corporation
  • 4. Carl Zeiss AG
  • 5. ClearSight
  • 6. Diamatrix Ltd.
  • 7. EssilorLuxottica
  • 8. Eyenovia, Inc.
  • 9. F. Hoffmann-La Roche AG
  • 10. GWS Surgicals LLP
  • 11. Haag-Streit Group by Metall Zug
  • 12. Halma PLC
  • 13. HEINE Optotechnik
  • 14. Honeywell International Inc.
  • 15. Hoya Corporation
  • 16. Johnson & Johnson Services, Inc.
  • 17. Luneau Technology Operations SAS
  • 18. Nidek Co. Ltd.
  • 19. Ophtec B.V.
  • 20. Ophtechnics Unlimited
  • 21. Paramount Surgimed Ltd.
  • 22. STAAR Surgical Company
  • 23. Stryker Corporation
  • 24. Topcon Corporation
  • 25. Unique Technologies, Inc.
  • 26. Ziemer Ophthalmic Systems AG
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦